These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1081903)

  • 1. Improvement in delayed hypersensitivity in Hodgkin's disease with transfer factor: lymphapheresis and cellular immune reactions or normal donors.
    Khan A; Hill JM; MacLellan A; Loeb E; Hill NO; Thaxton S
    Cancer; 1975 Jul; 36(1):86-9. PubMed ID: 1081903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer factor in Hodgkin's disease.
    Ng RP; Moran CJ; Alexopoulos CG; Bellingham AJ
    Lancet; 1975 Nov; 2(7941):901-3. PubMed ID: 53376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on delayed hypersensitivity of patients with Hodgkin's disease during remission.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(1):35-9. PubMed ID: 50967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Transfer of cell-mediated skin reactivity with "immune" RNA in Hodgkin's disease and other neoplastic diseases.
    Han T
    Cancer; 1974 Feb; 33(2):497-502. PubMed ID: 4130298
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of cell-mediated immune responses with transfer factor.
    Kirkpatrick CH
    Birth Defects Orig Artic Ser; 1975; 11(1):441-4. PubMed ID: 1096989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

  • 9. Transfer factor in Hodgkin's disease: a randomized clinical and immunological study.
    Hancock BW; Bruce L; Sokol RJ; Clark A
    Eur J Cancer Clin Oncol; 1988 May; 24(5):929-33. PubMed ID: 3049116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated Hodgkin's disease. Value of immunologic testing.
    Aisenberg AC
    JAMA; 1972 Dec; 222(10):1301-2. PubMed ID: 4678151
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assays in delayed hypersensitivity in the course of Hodgkin's disease].
    Bernadou A; Zittoun R; Blanc CM; Smadja R; Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):301-11. PubMed ID: 5507504
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of cell-mediated immunity to tuberculin using RNA from tuberculin-sensitive subjects.
    Han T; Pauly JL; Mittelman A
    Immunology; 1975 Jan; 28(1):127-32. PubMed ID: 1116867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Immune' RNA-mediated transfer of delayed skin reactivity in patients with Hodgkin's disease.
    Han T
    Clin Exp Immunol; 1973 Jun; 14(2):213-7. PubMed ID: 4717914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP
    Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-specificity of transfer factor.
    Khan A
    Ann Allergy; 1977 May; 38(5):320-2. PubMed ID: 855952
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of immunologic deficiency conditions by means of transfer factor].
    Kobielowa Z
    Pediatr Pol; 1975 Nov; 50(11):1393-7. PubMed ID: 1103073
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hodgkin's disease: study of delayed hypersensitivity of 64 non treated patients. Value of epicutaneous test using croton oil].
    Goasguen J; Leblay R; Guerin D; Le Prise PY; Richier JL
    Sem Hop; 1977 Jan; 53(4):219-25. PubMed ID: 189435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous basophil hypersensitivity uncovered in the cell transfer of classical tuberculin hypersensitivity.
    Askenase PW
    J Immunol; 1976 Sep; 117(3):741-7. PubMed ID: 1085308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.